Related Experiment Videos
Permanent decrease in activity of ornithine decarboxylase antizyme in rat liver during chemical hepatocarcinogenesis
Abstract:
This study was undertaken to determine whether or not there is failure of cellular control of L-ornithine decarboxylase activity by its antizyme, the only known natural intracellular inhibitor protein for L-ornithine decarboxylase activity, in rat liver during hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene. The formation of hepatic ornithine decarboxylase antizyme was elicited by i.p. injections of putrescine into rats fed a basal diet and rats fed the carcinogenic diet. The activities of both hepatic ornithine decarboxylase and hepatic ornithine decarboxylase antizyme were measured every month for five months, i.e., until hepatoma was fully developed. During azo-dye hepatocarcinogenesis and in fully developed hepatoma the activity of hepatic ornithine decarboxylase antizyme was always significantly lower than in normal resting liver, with minima at the second and the third months. The hepatoma does not synthesize ornithine decarboxylase antizyme more slowly than normal liver, since the difference could be neither abolished nor lessened by lengthening the time available for antizyme formation. Our results strongly suggest that the high intracellular putrescine levels in the livers of rats during 3'-methyl-4-dimethylaminoazobenzene hepatocarcinogenesis do not exert their normal control on hepatic ornithine decarboxylase activity because of a relative inability of these preneoplastic or neoplastic cells to make the ornithine decarboxylase antizyme.
Insights
Hepatocellular carcinoma involves a failure in cellular control of L-ornithine decarboxylase (ODC) activity. This occurs because preneoplastic and neoplastic cells exhibit an inability to produce sufficient ODC antizyme, the natural inhibitor of ODC.
Area of Science:
- Biochemistry
- Hepatology
- Carcinogenesis
Background:
- L-ornithine decarboxylase (ODC) activity is a key regulator of cell proliferation.
- ODC activity is primarily controlled by its natural intracellular inhibitor, ODC antizyme.
- Hepatocarcinogenesis involves alterations in cellular regulatory mechanisms.
Purpose of the Study:
- To investigate the role of ODC antizyme in cellular control during azo-dye-induced hepatocarcinogenesis in rats.
- To determine if ODC antizyme levels are altered in preneoplastic and neoplastic liver tissues.
- To elucidate the mechanism behind dysregulated ODC activity in liver cancer.
Main Methods:
- Induction of hepatocarcinogenesis in rats using 3'-methyl-4-dimethylaminoazobenzene.
- Monthly measurement of hepatic ornithine decarboxylase and ornithine decarboxylase antizyme activities over five months.
- Administration of putrescine to assess antizyme formation capacity in normal and cancerous liver tissues.
Main Results:
- Hepatic ODC antizyme activity was significantly lower in azo-dye-induced hepatocarcinogenesis and fully developed hepatoma compared to normal liver.
- The lowest levels of ODC antizyme activity were observed at the second and third months of carcinogenesis.
- Lengthening the time for antizyme formation did not restore ODC antizyme levels in hepatoma, indicating a synthetic defect.
Conclusions:
- The study suggests a failure in cellular control of ODC activity during hepatocarcinogenesis due to a reduced ability of preneoplastic/neoplastic cells to synthesize ODC antizyme.
- High intracellular putrescine levels in cancerous livers do not effectively inhibit ODC activity because of insufficient antizyme production.
- This impaired antizyme synthesis represents a critical mechanism contributing to ODC dysregulation in liver cancer development.